Xenon Pharmaceuticals
XENE
XENE
118 hedge funds and large institutions have $521M invested in Xenon Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 35 increasing their positions, 30 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.99% more ownership
Funds ownership: 81.94% → 82.93% (+0.99%)
22% less capital invested
Capital invested by funds: $671M → $521M (-$150M)
67% less funds holding in top 10
Funds holding in top 10: 6 → 2 (-4)
Holders
118
Holding in Top 10
2
Calls
$30.4M
Puts
$22.3M
Top Buyers
| 1 | +$10.7M | |
| 2 | +$8.65M | |
| 3 | +$8.63M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$5.24M |
| 5 |
TLP
Tri Locum Partners
New York
|
+$4.04M |
Top Sellers
| 1 | -$27.7M | |
| 2 | -$13.1M | |
| 3 | -$5.94M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$5.35M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$4.02M |